PT  - JOURNAL ARTICLE
AU  - Horne, Kyla-Louise
AU  - MacAskill, Michael R.
AU  - Myall, Daniel J.
AU  - Livingston, Leslie
AU  - Grenfell, Sophie
AU  - Pascoe, Maddie J.
AU  - Young, Bob
AU  - Shoorangiz, Reza
AU  - Melzer, Tracy R.
AU  - Pitcher, Toni L.
AU  - Anderson, Tim J.
AU  - Dalrymple-Alford, John C.
TI  - Neuropsychiatric symptoms are associated with dementia in Parkinson’s disease but not predictive of it
AID  - 10.1101/2020.09.01.20186312
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.01.20186312
4099  - http://medrxiv.org/content/early/2020/09/06/2020.09.01.20186312.short
4100  - http://medrxiv.org/content/early/2020/09/06/2020.09.01.20186312.full
AB  - Background Neuropsychiatric symptoms in Parkinson’s disease (PD) may increase dementia (PDD) risk. The predictive value of these symptoms, however, has not been compared to clinical and demographic predictors of future PDD.Methods 325 PD participants completed baseline neuropsychiatric and MDS-Task Force Level II assessments. Of these, 195 non-demented individuals were followed-up over a four-year period to detect conversion to PDD; 51 developed PDD. ROC analysis tested associations between baseline neuropsychiatric symptoms and conversion to PDD. The probability of developing PDD was also modelled as a function of neuropsychiatric inventory (NPI) total score, PD Questionnaire (PDQ) hallucinations, PDQ anxiety and contrasted to cognitive ability, age and motor function. Leave-one-out information criterion was used to evaluate which models provided useful information when predicting future PDD.Results The PDD group experienced greater levels of neuropsychiatric symptoms compared to the PD-MCI and PD-N groups at baseline. Few differences were found between the PD-MCI and PD-N groups. Five neuropsychiatric measures were significantly, but weakly, associated with future PDD. The strongest was NPI total score: AUC=0.66 [0.55-0.76]. There was, however, no evidence that it contained useful out-of-sample predictive information of future PDD (delta ELPD=1.6 (SD 2.4)); Similar results held for PDQ hallucinations and PDQ anxiety. In contrast, cognitive ability (delta ELPD=35 (SD 8)) and age (delta ELPD=11 (SD 5)) provided useful predictive information of future PDD.Conclusions Cognitive ability and age strongly out-performed neuropsychiatric measures as markers of developing PDD within four years. Therefore, neuropsychiatric symptoms do not appear to be useful markers of PDD risk.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe would like to acknowledge funding from the New Zealand Health Research Council, Brain Research New Zealand-Rangahau Roro Aotearoa, University of Otago, University of Canterbury, Neurological Foundation of New Zealand, Canterbury Medical Research Foundation, and the New Zealand Brain Research Institute.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Health and Disability Ethics Committee of the New Zealand Ministry of HealthAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data and code used for this analysis are currently available from the authors upon request. We are in the process of producing a properly anonymised dataset along with analysis code which will be made available for download, likely from the Open Science Framework website, with a link back to this pre-print.